You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

You’ve been redirected to the new Cancer Care Ontario website. You can also visit the archived website, which is no longer being maintained.

Chemotherapy or Radiotherapy for Resectable Pancreatic Adenocarcinoma

Version: 2-23 Version 2 ID: 2-23 Oct 2015
Type of Content: Guidelines & Advice, Clinical
Document Status: Education and Information
Authors:
Gastrointestinal Cancer Disease Site Group

Patient Population

Adult patients with resectable pancreatic adenocarcinoma for whom a pancreatectomy is planned.

Research Question(s)

Should patients with resectable adenocarcinoma of the exocrine pancreas receive preoperative or postoperative chemotherapy and/or radiation?

Outcomes of interest were overall survival, quality of life, and adverse effects.

pdf download Summary (PDF) (399.21 KB)